Log In
BCIQ
Print this Print this
 

Diprivan, propofol (Dipravan)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionPropofol
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsInduce anesthesia
Regulatory Designation
PartnerAspen Pharmacare Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$770.0M

$520.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/09/2016

$770.0M

$520.0M

0

Get a free BioCentury trial today